Bioluminescent sensor proteins for point-of-care therapeutic drug monitoring

Nature Chemical Biology

Volumn 10, Issue 7, 2014, Pages 598-603

  Griss, Rudolf ^a,b   Schena, Alberto ^a,b   Reymond, Luc ^a,b   Patiny, Luc ^a   Werner, Dominique ^c   Tinberg, Christine E ^d   Baker, David ^d   Johnsson, Kai ^a,b  

^a EPFL   (Switzerland)

^b Swiss National Centre of Competence in Research Robotics   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOSPORIN A; DIGOXIN; LUCIFERASE; METHOTREXATE; RAPAMYCIN; TACROLIMUS; TOPIRAMATE;

ARTICLE; BIOLUMINESCENCE; DRUG BLOOD LEVEL; DRUG MONITORING; HUMAN; PERFORMANCE; POINT OF CARE TESTING; PRIORITY JOURNAL; SENSOR;

ANTI-ARRHYTHMIA AGENTS; ANTICONVULSANTS; ANTINEOPLASTIC AGENTS; BIOSENSING TECHNIQUES; DRUG MONITORING; ESCHERICHIA COLI; GENE EXPRESSION; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOSUPPRESSIVE AGENTS; LUMINESCENT PROTEINS; PHOTOGRAPHY; POINT-OF-CARE SYSTEMS; PROTEIN ENGINEERING; RECOMBINANT FUSION PROTEINS;

EID: 84902839007     PISSN: 15524450     EISSN: 15524469     Source Type: Journal    
DOI: 10.1038/nchembio.1554     Document Type: Article

References (29)

1. Saint-Marcoux, F., Sauvage, F.L. & Marquet, P. Current role of LC-MS in therapeutic drug monitoring. Anal. Bioanal. Chem. 388, 1327-1349 (2007).
2. Brun, M.A., Tan, K.T., Nakata, E., Hinner, M.J. & Johnsson, K. Semisynthetic fluorescent sensor proteins based on self-labeling protein tags. J. Am. Chem. Soc. 131, 5873-5884 (2009).
3. Brun, M.A. et al. A semisynthetic fluorescent sensor protein for glutamate. J. Am. Chem. Soc. 134, 7676-7678 (2012).
4. Brun, M.A. et al. Semisynthesis of fluorescent metabolite sensors on cell surfaces. J. Am. Chem. Soc. 133, 16235-16242 (2011).
5. Masharina, A., Reymond, L., Maurel, D., Umezawa, K. & Johnsson, K. A fluorescent sensor for GABA and synthetic GABAB receptor ligands. J. Am. Chem. Soc. 134, 19026-19034 (2012).
6. Lennard, L. Therapeutic drug monitoring of cytotoxic drugs. Br. J. Clin. Pharmacol. 52 (suppl. 1): 75S-87S (2001).
7. Keppler, A. et al. A general method for the covalent labeling of fusion proteins with small molecules in vivo. Nat. Biotechnol. 21, 86-89 (2003).
8. Saito, K. et al. Auto-luminescent genetically-encoded ratiometric indicator for real-Time Ca2+ imaging at the single cell level. PLoS ONE 5, e9935 (2010).
9. Iwakura, M. & Nakamura, T. Effects of the length of a glycine linker connecting the N-And C-Termini of a circularly permuted dihydrofolate reductase. Protein Eng. 11, 707-713 (1998).
10. Jaffe, N. & Gorlick, R. High-dose methotrexate in osteosarcoma: Let the questions surcease-Time for final acceptance. J. Clin. Oncol. 26, 4365-4366 (2008).
11. Al-Turkmani, M.R., Law, T., Narla, A. & Kellogg, M.D. Difficulty measuring methotrexate in a patient with high-dose methotrexate-induced nephrotoxicity. Clin. Chem. 56, 1792-1794 (2010).
12. Kratz, A., Ferraro, M., Sluss, P.M. & Lewandrowski, K.B. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Laboratory reference values. N. Engl. J. Med. 351, 1548-1563 (2004); erratum 351, 2461.
13. Pollock, N.R. et al. A paper-based multiplexed transaminase test for low-cost, point-of-care liver function testing. Sci. Transl. Med. 4, 152ra129 (2012).
14. Armstrong, V.W. & Oellerich, M. New developments in the immunosuppressive drug monitoring of cyclosporine, tacrolimus, and azathioprine. Clin. Biochem. 34, 9-16 (2001).
15. Röhrig, C.H., Loch, C., Guan, J.Y., Siegal, G. & Overhand, M. Fragment-based synthesis and SAR of modified FKBP ligands: Influence of different linking on binding affinity. ChemMedChem 2, 1054-1070 (2007).
16. Patsalos, P.N. et al. Antiepileptic drugs-best practice guidelines for therapeutic drug monitoring: A position paper by the subcommission on therapeutic drug monitoring, ILAE Commission on Therapeutic Strategies. Epilepsia 49, 1239-1276 (2008).
17. Valdes, R. Jr., Jortani, S.A. & Gheorghiade, M. Standards of laboratory practice: Cardiac drug monitoring. National Academy of Clinical Biochemistry. Clin. Chem. 44, 1096-1109 (1998).
18. Matsui, H. & Schwartz, A. Mechanism of cardiac glycoside inhibition of the (Na+-K+)-dependent ATPase from cardiac tissue. Biochim. Biophys. Acta 151, 655-663 (1968).
19. Tinberg, C.E. et al. Computational design of ligand-binding proteins with high affinity and selectivity. Nature 501, 212-216 (2013).
20. Terra, S.G., Washam, J.B., Dunham, G.D. & Gattis, W.A. Therapeutic range of digoxin's efficacy in heart failure: What is the evidence? Pharmacotherapy 19, 1123-1126 (1999).
21. Smith, T.W. & Haber, E. Digoxin intoxication: The relationship of clinical presentation to serum digoxin concentration. J. Clin. Invest. 49, 2377-2386 (1970).
22. Turner, A.P. Biosensors: Sense and sensibility. Chem. Soc. Rev. 42, 3184-3196 (2013).
23. Krishnamurthy, V.M., Semetey, V., Bracher, P.J., Shen, N. & Whitesides, G.M. Dependence of effective molarity on linker length for an intramolecular protein-ligand system. J. Am. Chem. Soc. 129, 1312-1320 (2007).
24. Sawaya, M.R. & Kraut, J. Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: Crystallographic evidence. Biochemistry 36, 586-603 (1997).
25. Dubowchik, G.M. et al. 2-Aryl-2,2-difluoroacetamide FKBP12 ligands: Synthesis and X-ray structural studies. Org. Lett. 3, 3987-3990 (2001).
26. Schulz, M. & Schmoldt, A. Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics. Pharmazie 58, 447-474 (2003).
27. Srivastava, D.K. et al. Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II. J. Am. Chem. Soc. 129, 5528-5537 (2007).
28. Schneider, C.A., Rasband, W.S. & Eliceiri, K.W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671-675 (2012).
29. Li, C.H. & Tam, P.K.S. An iterative algorithm for minimum cross entropy thresholding. Pattern Recognit. Lett. 19, 771-776 (1998).